© 1996 Medical Council on Alcohol
article-commentary
ALCOHOL DEPENDENCE: A COMMENTARY ON MECHANISMS
Department of Pharmacology, University of Colorado Health Sciences Center Box C236, 4200 East Ninth Avenue, Denver, Colorado 80262, USA
*Author to whom correspondence should be addressed
Received 23 November 1995;
The alcohol dependence syndrome includes the presence of alcohol tolerance, physical dependence and an inability to control one's alcohol intake. Studies are reviewed that implicate the mesolimbic dopaminergic systems, and the 
-aminobutyric acid-A (GABAA) and N-methyl-D-aspartate (NMDA) receptors as mediators of various aspects of the alcohol dependence syndrome. It is suggested that alcohol-induced changes in the GABAA receptor may play a role in certain aspects of tolerance to alcohol and in altered abilities of an individual to terminate alcohol intake. Chronic alcohol-induced increases in the activity of NMDA receptors may contribute to the withdrawal signs that are the defining feature of physical dependence on alcohol. It is hypothesized that decreased mesolimbic dopaminergic function, which occurs during alcohol withdrawal, may be involved in the compulsion to initiate and maintain alcohol drinking, another aspect of the alcohol dependence syndrome. Furthermore, evidence is presented that this decreased dopaminergic function could occur secondarily to the increase in NMDA receptor function, such that the alcohol-induced increase in NMDA receptor function could underlie both the overt withdrawal signs and the compulsion to drink alcohol in the alcohol-dependent individual.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. A. Schuckit, T. L. Smith, R. S. Trim, J. Heron, J. Horwood, J. Davis, J. Hibbeln, and the ALSPAC Study Team The Self-Rating of the Effects of Alcohol Questionnaire as a Predictor of Alcohol-Related Outcomes in 12-Year-Old Subjects Alcohol Alcohol., November 1, 2008; 43(6): 641 - 646. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Krystal, J. Staley, G. Mason, I. L. Petrakis, J. Kaufman, R. A. Harris, J. Gelernter, and J. Lappalainen {gamma}-Aminobutyric Acid Type A Receptors and Alcoholism: Intoxication, Dependence, Vulnerability, and Treatment. Arch Gen Psychiatry, September 1, 2006; 63(9): 957 - 968. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Butt, N. M. King, J. A. Stitzel, and A. C. Collins Interaction of the Nicotinic Cholinergic System with Ethanol Withdrawal J. Pharmacol. Exp. Ther., February 1, 2004; 308(2): 591 - 599. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. T. Harris, J. D. Roache, and J. E. Thornton A ROLE FOR VALPROATE IN THE TREATMENT OF SEDATIVE-HYPNOTIC WITHDRAWAL AND FOR RELAPSE PREVENTION Alcohol Alcohol., July 1, 2000; 35(4): 319 - 323. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Mikolajczak, I. Okulicz-Kozaryn, K. Szczawinska, E. Kaminska, and K. Kus ZOLPIDEM INVOLVEMENT ON MEMORY AND HYPNOTIC EFFECT OF ETHANOL IN CHRONICALLY ETHANOL-TREATED RATS Alcohol Alcohol., July 1, 1999; 34(4): 511 - 519. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Thompson PLATELET AND ERYTHROCYTE MEMBRANE FLUIDITY CHANGES IN ALCOHOL-DEPENDENT PATIENTS UNDERGOING ACUTE WITHDRAWAL Alcohol Alcohol., May 1, 1999; 34(3): 349 - 354. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. D. Spies and H. Rommelspacher Alcohol Withdrawal in the Surgical Patient: Prevention and Treatment Anesth. Analg., April 1, 1999; 88(4): 946 - 946. [Full Text] [PDF]
|
|